[English] 日本語
Yorodumi- PDB-3zjf: A20 OTU domain with irreversibly oxidised Cys103 from 270 min H2O... -
+Open data
-Basic information
Entry | Database: PDB / ID: 3zjf | ||||||
---|---|---|---|---|---|---|---|
Title | A20 OTU domain with irreversibly oxidised Cys103 from 270 min H2O2 soak. | ||||||
Components | (A20P50) x 2 | ||||||
Keywords | HYDROLASE / UBIQUITIN / DEUBIQUITINATING ENZYME / REVERSIBLE OXIDATION / SULPHENIC ACID / CYS PROTEASE | ||||||
Function / homology | Function and homology information regulation of vascular wound healing / negative regulation of toll-like receptor 5 signaling pathway / negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway / establishment of protein localization to vacuole / negative regulation of osteoclast proliferation / tolerance induction to lipopolysaccharide / negative regulation of CD40 signaling pathway / negative regulation of toll-like receptor 3 signaling pathway / protein K33-linked deubiquitination / protein K29-linked deubiquitination ...regulation of vascular wound healing / negative regulation of toll-like receptor 5 signaling pathway / negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway / establishment of protein localization to vacuole / negative regulation of osteoclast proliferation / tolerance induction to lipopolysaccharide / negative regulation of CD40 signaling pathway / negative regulation of toll-like receptor 3 signaling pathway / protein K33-linked deubiquitination / protein K29-linked deubiquitination / negative regulation of B cell activation / negative regulation of chronic inflammatory response / negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway / protein deubiquitination involved in ubiquitin-dependent protein catabolic process / negative regulation of toll-like receptor 2 signaling pathway / protein K11-linked deubiquitination / nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway / negative regulation of toll-like receptor 4 signaling pathway / regulation of germinal center formation / B-1 B cell homeostasis / regulation of defense response to virus by host / protein K48-linked deubiquitination / regulation of tumor necrosis factor-mediated signaling pathway / Transferases; Acyltransferases; Aminoacyltransferases / positive regulation of hepatocyte proliferation / protein K63-linked deubiquitination / negative regulation of bone resorption / TNFR1-induced proapoptotic signaling / negative regulation of interleukin-1 beta production / K63-linked deubiquitinase activity / negative regulation of NF-kappaB transcription factor activity / negative regulation of interleukin-2 production / K63-linked polyubiquitin modification-dependent protein binding / response to muramyl dipeptide / negative regulation of interleukin-6 production / negative regulation of tumor necrosis factor production / positive regulation of Wnt signaling pathway / protein deubiquitination / protein K48-linked ubiquitination / negative regulation of endothelial cell apoptotic process / negative regulation of canonical NF-kappaB signal transduction / negative regulation of extrinsic apoptotic signaling pathway via death domain receptors / cytoskeleton organization / negative regulation of protein ubiquitination / negative regulation of innate immune response / ubiquitin binding / TNFR1-induced NF-kappa-B signaling pathway / Negative regulators of DDX58/IFIH1 signaling / negative regulation of smooth muscle cell proliferation / Regulation of TNFR1 signaling / response to molecule of bacterial origin / NOD1/2 Signaling Pathway / kinase binding / negative regulation of inflammatory response / cellular response to hydrogen peroxide / ubiquitin-protein transferase activity / positive regulation of protein catabolic process / Ovarian tumor domain proteases / cell migration / cellular response to lipopolysaccharide / protease binding / ubiquitinyl hydrolase 1 / cysteine-type deubiquitinase activity / lysosome / inflammatory response / apoptotic process / DNA binding / extracellular exosome / zinc ion binding / identical protein binding / nucleus / cytosol / cytoplasm Similarity search - Function | ||||||
Biological species | HOMO SAPIENS (human) | ||||||
Method | X-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 2.2 Å | ||||||
Authors | Kulathu, Y. / Garcia, F.J. / Mevissen, T.E.T. / Busch, M. / Arnaudo, N. / Carroll, K.S. / Barford, D. / Komander, D. | ||||||
Citation | Journal: Nat.Commun. / Year: 2013 Title: Regulation of A20 and Other Otu Deubiquitinases by Reversible Oxidation Authors: Kulathu, Y. / Garcia, F.J. / Mevissen, T.E.T. / Busch, M. / Arnaudo, N. / Carroll, K.S. / Barford, D. / Komander, D. | ||||||
History |
|
-Structure visualization
Structure viewer | Molecule: MolmilJmol/JSmol |
---|
-Downloads & links
-Download
PDBx/mmCIF format | 3zjf.cif.gz | 275.7 KB | Display | PDBx/mmCIF format |
---|---|---|---|---|
PDB format | pdb3zjf.ent.gz | 222.6 KB | Display | PDB format |
PDBx/mmJSON format | 3zjf.json.gz | Tree view | PDBx/mmJSON format | |
Others | Other downloads |
-Validation report
Summary document | 3zjf_validation.pdf.gz | 440.7 KB | Display | wwPDB validaton report |
---|---|---|---|---|
Full document | 3zjf_full_validation.pdf.gz | 449.5 KB | Display | |
Data in XML | 3zjf_validation.xml.gz | 25.6 KB | Display | |
Data in CIF | 3zjf_validation.cif.gz | 35.8 KB | Display | |
Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/zj/3zjf ftp://data.pdbj.org/pub/pdb/validation_reports/zj/3zjf | HTTPS FTP |
-Related structure data
Related structure data | 3zjdC 3zjeC 3zjgC 2vfjS C: citing same article (ref.) S: Starting model for refinement |
---|---|
Similar structure data |
-Links
-Assembly
Deposited unit |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
Unit cell |
|
-Components
#1: Protein | Mass: 43165.504 Da / Num. of mol.: 1 / Fragment: OTU DOMAIN, RESIDUES 1-366 / Mutation: YES Source method: isolated from a genetically manipulated source Details: THE CATALYTIC CYS103 IS IRREVERSIBLY OXIDISED AND MODELLED AS CYS SULPHINIC ACID (SO2H). Source: (gene. exp.) HOMO SAPIENS (human) / Production host: ESCHERICHIA COLI (E. coli) / Strain (production host): BL21 References: UniProt: P21580, ubiquitinyl hydrolase 1, Ligases; Forming carbon-nitrogen bonds; Acid-amino-acid ligases (peptide synthases) | ||
---|---|---|---|
#2: Protein | Mass: 43181.504 Da / Num. of mol.: 1 / Fragment: OTU DOMAIN, RESIDUES 1-366 / Mutation: YES Source method: isolated from a genetically manipulated source Details: THE CATALYTIC CYS103 IS IRREVERSIBLY OXIDISED AND MODELLED AS CYS SULPHONIC ACID (SO3H). Source: (gene. exp.) HOMO SAPIENS (human) / Production host: ESCHERICHIA COLI (E. coli) / Strain (production host): BL21 References: UniProt: P21580, ubiquitinyl hydrolase 1, Ligases; Forming carbon-nitrogen bonds; Acid-amino-acid ligases (peptide synthases) | ||
#3: Chemical | #4: Water | ChemComp-HOH / | |
-Experimental details
-Experiment
Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
---|
-Sample preparation
Crystal | Density Matthews: 2.85 Å3/Da / Density % sol: 56 % / Description: NONE |
---|---|
Crystal grow | pH: 6.2 Details: 2-2.5 M NACL, 0.1 M MES [PH 6-6.7]. CRYSTALS WERE SOAKED IN 50 UM H2O2 FOR 270 MIN PRIOR TO FREEZING AND DATA COLLECTION. |
-Data collection
Diffraction | Mean temperature: 100 K |
---|---|
Diffraction source | Source: SYNCHROTRON / Site: Diamond / Beamline: I02 / Wavelength: 0.92 |
Detector | Type: ADSC QUANTUM 315 / Detector: CCD / Date: Jan 27, 2008 |
Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
Radiation wavelength | Wavelength: 0.92 Å / Relative weight: 1 |
Reflection | Resolution: 2.2→38.18 Å / Num. obs: 45957 / % possible obs: 95.2 % / Observed criterion σ(I): 2 / Redundancy: 3 % / Biso Wilson estimate: 36.38 Å2 / Rmerge(I) obs: 0.06 / Net I/σ(I): 13.2 |
Reflection shell | Resolution: 2.2→2.32 Å / Redundancy: 3 % / Rmerge(I) obs: 0.5 / Mean I/σ(I) obs: 2.2 / % possible all: 95.2 |
-Processing
Software |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Refinement | Method to determine structure: MOLECULAR REPLACEMENT Starting model: PDB ENTRY 2VFJ Resolution: 2.2→34.272 Å / SU ML: 0.27 / σ(F): 2 / Phase error: 24.08 / Stereochemistry target values: ML Details: SIDE CHAINS OF SEVERAL RESIDUES WERE NOT MODELLED DUE TO DISORDER. SOME SURFACE LOOPS ARE MISSING FROM THE STRUCTURE. CYS103 WAS MODELLED AS SULPHINIC AND SULPHONIC ACID IN CHAIN A AND B, ...Details: SIDE CHAINS OF SEVERAL RESIDUES WERE NOT MODELLED DUE TO DISORDER. SOME SURFACE LOOPS ARE MISSING FROM THE STRUCTURE. CYS103 WAS MODELLED AS SULPHINIC AND SULPHONIC ACID IN CHAIN A AND B, RESPECTIVELY. SEVERAL RESIDUES WERE MODELLED WITH WITH OCCUPANCY SET TO 0 OR WITH SIDE CHAINS REMOVED.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Solvent computation | Shrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refinement step | Cycle: LAST / Resolution: 2.2→34.272 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refine LS restraints |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LS refinement shell |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refinement TLS params. | Method: refined / Refine-ID: X-RAY DIFFRACTION
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refinement TLS group |
|